FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316235576> ?p ?o ?g. }

• W2316235576 abstract "Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FLNon-small cell lung cancers (NSCLC) driven by ligand-independent activating mutations in epidermal growth factor receptor (EGFR) often respond to treatment with EGFR tyrosine kinase inhibitors (TKIs). About half of acquired resistance to EGFR-TKI therapy results from a secondary point mutation in the EGFR tyrosine kinase domain at amino acid position 790 (T790M). T790M mutants also display reduced sensitivity to Cetuximab treatment. We have investigated the molecular mechanism responsible for the reduced Cetuximab sensitivity and found that T790M mutant receptors primarily exist and signal as monomers. We have exploited this characteristic of the T790M mutant to isolate novel EGFR inhibitory antibodies with activities against all EGFR variants.In addition, as opposed to other EGFR inhibitory antibodies, these novel antibodies have reduced ligand binding inhibitory activity and minimal inhibitory effect on EGF induced human primary keratinocyte proliferation, suggesting a potentially reduced skin toxicity profile. The broad activity profile, combined with potentially reduced skin toxicity, suggests that these antibodies will have great potential for combinability with other therapeutic agents.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 642. doi:10.1158/1538-7445.AM2011-642" @default.
• W2316235576 created "2016-06-24" @default.
• W2316235576 creator A5002661071 @default.
• W2316235576 creator A5003184548 @default.
• W2316235576 creator A5004475653 @default.
• W2316235576 creator A5009223410 @default.
• W2316235576 creator A5018021099 @default.
• W2316235576 creator A5019052465 @default.
• W2316235576 creator A5019508653 @default.
• W2316235576 creator A5019745981 @default.
• W2316235576 creator A5032202587 @default.
• W2316235576 creator A5036435005 @default.
• W2316235576 creator A5050296200 @default.
• W2316235576 creator A5066434843 @default.
• W2316235576 creator A5091216677 @default.
• W2316235576 date "2011-04-15" @default.
• W2316235576 modified "2023-10-18" @default.
• W2316235576 title "Abstract 642: Novel EGFR inhibitory antibodies directed against EGFR mutants with potentially reduced toxicity" @default.
• W2316235576 doi "https://doi.org/10.1158/1538-7445.am2011-642" @default.
• W2316235576 hasPublicationYear "2011" @default.
• W2316235576 type Work @default.
• W2316235576 sameAs 2316235576 @default.
• W2316235576 citedByCount "0" @default.
• W2316235576 crossrefType "proceedings-article" @default.
• W2316235576 hasAuthorship W2316235576A5002661071 @default.
• W2316235576 hasAuthorship W2316235576A5003184548 @default.
• W2316235576 hasAuthorship W2316235576A5004475653 @default.
• W2316235576 hasAuthorship W2316235576A5009223410 @default.
• W2316235576 hasAuthorship W2316235576A5018021099 @default.
• W2316235576 hasAuthorship W2316235576A5019052465 @default.
• W2316235576 hasAuthorship W2316235576A5019508653 @default.
• W2316235576 hasAuthorship W2316235576A5019745981 @default.
• W2316235576 hasAuthorship W2316235576A5032202587 @default.
• W2316235576 hasAuthorship W2316235576A5036435005 @default.
• W2316235576 hasAuthorship W2316235576A5050296200 @default.
• W2316235576 hasAuthorship W2316235576A5066434843 @default.
• W2316235576 hasAuthorship W2316235576A5091216677 @default.
• W2316235576 hasConcept C104317684 @default.
• W2316235576 hasConcept C121608353 @default.
• W2316235576 hasConcept C126322002 @default.
• W2316235576 hasConcept C143065580 @default.
• W2316235576 hasConcept C159654299 @default.
• W2316235576 hasConcept C170493617 @default.
• W2316235576 hasConcept C185592680 @default.
• W2316235576 hasConcept C203014093 @default.
• W2316235576 hasConcept C2777506169 @default.
• W2316235576 hasConcept C2777930144 @default.
• W2316235576 hasConcept C2779438470 @default.
• W2316235576 hasConcept C2779998722 @default.
• W2316235576 hasConcept C2780580887 @default.
• W2316235576 hasConcept C29730261 @default.
• W2316235576 hasConcept C42362537 @default.
• W2316235576 hasConcept C502942594 @default.
• W2316235576 hasConcept C542903549 @default.
• W2316235576 hasConcept C55493867 @default.
• W2316235576 hasConcept C71924100 @default.
• W2316235576 hasConcept C98274493 @default.
• W2316235576 hasConceptScore W2316235576C104317684 @default.
• W2316235576 hasConceptScore W2316235576C121608353 @default.
• W2316235576 hasConceptScore W2316235576C126322002 @default.
• W2316235576 hasConceptScore W2316235576C143065580 @default.
• W2316235576 hasConceptScore W2316235576C159654299 @default.
• W2316235576 hasConceptScore W2316235576C170493617 @default.
• W2316235576 hasConceptScore W2316235576C185592680 @default.
• W2316235576 hasConceptScore W2316235576C203014093 @default.
• W2316235576 hasConceptScore W2316235576C2777506169 @default.
• W2316235576 hasConceptScore W2316235576C2777930144 @default.
• W2316235576 hasConceptScore W2316235576C2779438470 @default.
• W2316235576 hasConceptScore W2316235576C2779998722 @default.
• W2316235576 hasConceptScore W2316235576C2780580887 @default.
• W2316235576 hasConceptScore W2316235576C29730261 @default.
• W2316235576 hasConceptScore W2316235576C42362537 @default.
• W2316235576 hasConceptScore W2316235576C502942594 @default.
• W2316235576 hasConceptScore W2316235576C542903549 @default.
• W2316235576 hasConceptScore W2316235576C55493867 @default.
• W2316235576 hasConceptScore W2316235576C71924100 @default.
• W2316235576 hasConceptScore W2316235576C98274493 @default.
• W2316235576 hasLocation W23162355761 @default.
• W2316235576 hasOpenAccess W2316235576 @default.
• W2316235576 hasPrimaryLocation W23162355761 @default.
• W2316235576 hasRelatedWork W1565370786 @default.
• W2316235576 hasRelatedWork W1821945583 @default.
• W2316235576 hasRelatedWork W1965872502 @default.
• W2316235576 hasRelatedWork W1980984439 @default.
• W2316235576 hasRelatedWork W1991580010 @default.
• W2316235576 hasRelatedWork W1998344649 @default.
• W2316235576 hasRelatedWork W2039178120 @default.
• W2316235576 hasRelatedWork W2094111402 @default.
• W2316235576 hasRelatedWork W2097775552 @default.
• W2316235576 hasRelatedWork W2126709309 @default.
• W2316235576 hasRelatedWork W2143913849 @default.
• W2316235576 hasRelatedWork W2200479345 @default.
• W2316235576 hasRelatedWork W2267445858 @default.
• W2316235576 hasRelatedWork W2322301907 @default.
• W2316235576 hasRelatedWork W2488517969 @default.
• W2316235576 hasRelatedWork W2488622084 @default.
• W2316235576 hasRelatedWork W2553214361 @default.
• W2316235576 hasRelatedWork W2567203443 @default.
• W2316235576 hasRelatedWork W2953930977 @default.
• W2316235576 hasRelatedWork W2956077966 @default.

• next